These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27152859)

  • 1. Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.
    Yano S; Takehara K; Zhao M; Tan Y; Han Q; Li S; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2016 Jul; 15(13):1715-23. PubMed ID: 27152859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methioninase Cell-Cycle Trap Cancer Chemotherapy.
    Hoffman RM; Yano S; Igarashi K
    Methods Mol Biol; 2019; 1866():133-148. PubMed ID: 30725413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li S; Han Q; Tan Y; Zhao M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(6):801-809. PubMed ID: 29374999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.
    Yano S; Zhang Y; Zhao M; Hiroshima Y; Miwa S; Uehara F; Kishimoto H; Tazawa H; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2014; 13(24):3958-63. PubMed ID: 25483077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella typhimurium A1-R and Cell-Cycle Decoy Therapy of Cancer.
    Hoffman RM; Yano S
    Methods Mol Biol; 2016; 1409():165-75. PubMed ID: 26846810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional Gelfoam® histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging.
    Yano S; Miwa S; Mii S; Hiroshima Y; Uehara F; Kishimoto H; Tazawa H; Zhao M; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2015; 14(6):808-19. PubMed ID: 25564963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity.
    Yano S; Li S; Han Q; Tan Y; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2014 Sep; 5(18):8729-36. PubMed ID: 25238266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
    Cell Cycle; 2017 Mar; 16(5):406-414. PubMed ID: 27715464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model.
    Miyake K; Kiyuna T; Li S; Han Q; Tan Y; Zhao M; Oshiro H; Kawaguchi K; Higuchi T; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Murakami T; Singh AS; Li Y; Nelson SD; Eilber FC; Bouvet M; Hiroshima Y; Chishima T; Matsuyama R; Singh SR; Endo I; Hoffman RM
    Chemotherapy; 2018; 63(5):278-283. PubMed ID: 30673664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Cell-Cycle Decoying Killer Adenovirus on 3-D Gelfoam®-Histoculture and Tumor-Sphere Models of Chemo-Resistant Stomach Carcinomatosis Visualized by FUCCI Imaging.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
    PLoS One; 2016; 11(9):e0162991. PubMed ID: 27673332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
    J Cell Biochem; 2017 Nov; 118(11):3635-3642. PubMed ID: 27171483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Specific S/G
    Hoffman RM; Yano S
    Methods Mol Biol; 2019; 1866():49-60. PubMed ID: 30725407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness.
    Yano S; Zhang Y; Miwa S; Tome Y; Hiroshima Y; Uehara F; Yamamoto M; Suetsugu A; Kishimoto H; Tazawa H; Zhao M; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2014; 13(13):2110-9. PubMed ID: 24811200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FUCCI Real-Time Cell-Cycle Imaging as a Guide for Designing Improved Cancer Therapy: A Review of Innovative Strategies to Target Quiescent Chemo-Resistant Cancer Cells.
    Yano S; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32957652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Methioninase Combined With Tumor-targeting
    Igarashi K; Kawaguchi K; Zhao M; Han Q; Tan Y; Kiyuna T; Miyake K; Higuchi T; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM
    Anticancer Res; 2020 May; 40(5):2515-2523. PubMed ID: 32366396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.
    Kawaguchi K; Higuchi T; Li S; Han Q; Tan Y; Igarashi K; Zhao M; Miyake K; Kiyuna T; Miyake M; Ohshiro H; Sugisawa N; Zhang Z; Razmjooei S; Wangsiricharoen S; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Eckardt MA; Singh AS; Singh SR; Eilber FC; Unno M; Hoffman RM
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3086-3092. PubMed ID: 30166061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
    Yano S; Tazawa H; Hashimoto Y; Shirakawa Y; Kuroda S; Nishizaki M; Kishimoto H; Uno F; Nagasaka T; Urata Y; Kagawa S; Hoffman RM; Fujiwara T
    Clin Cancer Res; 2013 Dec; 19(23):6495-505. PubMed ID: 24081978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging.
    Miwa S; Yano S; Kimura H; Yamamoto M; Toneri M; Matsumoto Y; Uehara F; Hiroshima Y; Murakami T; Hayashi K; Yamamoto N; Bouvet M; Fujiwara T; Tsuchiya H; Hoffman RM
    Cell Cycle; 2015; 14(4):621-9. PubMed ID: 25551170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging.
    Yano S; Miwa S; Mii S; Hiroshima Y; Uehara F; Yamamoto M; Kishimoto H; Tazawa H; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2014; 13(6):953-60. PubMed ID: 24552821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of oral recombinant methioninase (rMETase) and 5-fluorouracil on poorly differentiated gastric cancer.
    Miyake M; Miyake K; Han Q; Igarashi K; Kawaguchi K; Barangi M; Kiyuna T; Sugisawa N; Higuchi T; Oshiro H; Zhang Z; Razmjooei S; Bouvet M; Endo I; Hoffman RM
    Biochem Biophys Res Commun; 2023 Feb; 643():48-54. PubMed ID: 36586158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.